de Zeeuw D - Search Results

1

Variability in response to albuminuria-lowering drugs: true or random?

Petrykiv SI, de Zeeuw D, Persson F, Rossing P, Gansevoort RT, Laverman GD, Heerspink HJL. Petrykiv SI, et al. Among authors: de zeeuw d. Br J Clin Pharmacol. 2017 Jun;83(6):1197-1204. doi: 10.1111/bcp.13217. Epub 2017 Feb 1. Br J Clin Pharmacol. 2017. PMID: 28002889 Free PMC article.

2

Dual renin-angiotensin system blockade at optimal doses for proteinuria.

Laverman GD, Navis G, Henning RH, de Jong PE, de Zeeuw D. Laverman GD, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2002 Sep;62(3):1020-5. doi: 10.1046/j.1523-1755.2002.00536.x. Kidney Int. 2002. PMID: 12164886 Free article. Clinical Trial.

3

Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.

Laverman GD, Van Goor H, Henning RH, De Jong PE, De Zeeuw D, Navis G. Laverman GD, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 2003 Jan;63(1):64-71. doi: 10.1046/j.1523-1755.2003.00708.x. Kidney Int. 2003. PMID: 12472769 Free article.

4

Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?

Laverman GD, de Zeeuw D, Navis G. Laverman GD, et al. Among authors: de zeeuw d. J Renin Angiotensin Aldosterone Syst. 2002 Dec;3(4):205-13. doi: 10.3317/jraas.2002.042. J Renin Angiotensin Aldosterone Syst. 2002. PMID: 12584664 Free article. Review.

5

The COOPERATE trial.

Vogt L, Laverman GD, de Zeeuw D, Navis G. Vogt L, et al. Among authors: de zeeuw d. Lancet. 2003 Mar 22;361(9362):1055-6. doi: 10.1016/S0140-6736(03)12803-6. Lancet. 2003. PMID: 12660079 No abstract available.

6

Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.

Bos H, Laverman GD, Henning RH, Tiebosch AT, de Jong PE, de Zeeuw D, Navis G. Bos H, et al. Among authors: de jong pe, de zeeuw d. J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):106-12. doi: 10.3317/jraas.2003.010. J Renin Angiotensin Aldosterone Syst. 2003. PMID: 12806593 Free article.

7

Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.

Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE. Verhave JC, et al. Among authors: de jong pe, de zeeuw d. J Am Soc Nephrol. 2004 May;15(5):1316-22. J Am Soc Nephrol. 2004. PMID: 15100372

8

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. de Zeeuw D, et al. Circulation. 2004 Aug 24;110(8):921-7. doi: 10.1161/01.CIR.0000139860.33974.28. Epub 2004 Aug 9. Circulation. 2004. PMID: 15302780 Clinical Trial.

9

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.

Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE; PREVEND Study Group. Verhave JC, et al. Among authors: de jong pe, de zeeuw d. Kidney Int Suppl. 2004 Nov;(92):S18-21. doi: 10.1111/j.1523-1755.2004.09205.x. Kidney Int Suppl. 2004. PMID: 15485409 Review.

10

Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?

de Zeeuw D. de Zeeuw D. Kidney Int Suppl. 2004 Nov;(92):S2-6. doi: 10.1111/j.1523-1755.2004.09201.x. Kidney Int Suppl. 2004. PMID: 15485410 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters